The TESS Research Foundation Rolling Grant Program supports research related to the disorder caused by mutations in the SLC13A5 gene. TESS Research Foundation aims to provide seed funding for projects leading to sustainable funding from outside organizations. Research plans should directly or indirectly address one of the following high-priority areas:
- SLC13A5 biology
- Model development and characterization
- Clinical development
- Developing new therapies
Preference is given to projects that address more than one priority area. Applications are open to independent researchers, whether tenure-track faculty, non-tenure-track faculty or staff, or an equivalent level at a research institution or a biotechnology/pharmaceutical company. The award may support laboratory supplies, personnel costs, or services necessary to conduct the proposed research.
The funding provides up to 100,000 USD for one or two years. No indirect costs are permitted. Smaller projects are allowed and encouraged.
Applications are accepted on a rolling basis.